Evidence map›Paper›PMID 23408858›Full record

ArticleNucleic acids research2013

Novel inhibition of archaeal family-D DNA polymerase by uracil.

Tomas T Richardson, Louise Gilroy, Yoshizumi Ishino, Bernard A Connolly, Ghislaine Henneke

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Archaeal replicative primases can perform translesion DNA synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tomas T RichardsonInstitute for Cell and Molecular Biosciences (ICaMB), Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Louise Gilroy
Yoshizumi Ishino
Bernard A Connolly
Ghislaine Henneke
Biology of Extremophiles Laboratory · FRKyushu University · JP

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Archaeal family-D DNA polymerase is inhibited by the presence of uracil in DNA template strands. When the enzyme encounters uracil, following three parameters change: DNA binding increases roughly 2-fold, the rate of polymerization slows by a factor of ≈ 5 and 3'-5' proof-reading exonuclease activity is stimulated by a factor of ≈ 2. Together these changes result in a significant decrease in polymerization activity and a reduction in net DNA synthesis. Pol D appears to interact with template strand uracil irrespective of its distance ahead of the replication fork. Polymerization does not stop at a defined location relative to uracil, rather a general decrease in DNA synthesis is observed. 'Trans' inhibition, the slowing of Pol D by uracil on a DNA strand not being replicated is also observed. It is proposed that Pol D is able to interact with uracil by looping out the single-stranded template, allowing simultaneous contact of both the base and the primer-template junction to give a polymerase-DNA complex with diminished extension ability.

Indexed as

Deoxyadenine NucleotidesDeoxyribonucleotidesDNADNA-Directed DNA PolymeraseDNA, Single-StrandedExonucleasesNucleic Acid Synthesis InhibitorsPyrococcusTemplates, GeneticUracil2'-deoxy-5'-adenosine monophosphateDeoxyadenine NucleotidesDeoxyribonucleotidesDNADNA-Directed DNA PolymeraseDNA, Single-StrandedExonucleasesNucleic Acid Synthesis InhibitorsUracil

Identifiers

PMID23408858
PMCPMC3627576
OpenAlexW2171640958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.